Approval · Notice of Compliance 8012 · 2006
TEVETEN: Notice of Compliance 8012
Issued June 5, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8012
- Date
- June 5, 2006
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updating the indication for the treatment of mild to moderate essential hypertension
- Therapeutic class
- Angiotensin ii receptor (at1) antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVETEN | Not yet assigned | — |
Medicinal ingredients
- EPROSARTAN MESYLATE 400 MG per TAB
- EPROSARTAN MESYLATE 600 MG per TAB